Ukr.Biochem.J. 2026; Volume 98, Issue 3, May-Jun, pp. 83-92

doi: https://doi.org/10.15407/ubj98.03.083

Serum apelin and corin as biochemical markers of polycystic ovary syndrome

09.06.2026   Uncategorized

A. M. Ajeed1, R. J. Kadhim2, N. J. Abbas3, N. A. Nasser4*

1Al-Turath University, College of Pharmacy, Baghdad, Iraq;
2Department of Biotechnology, College of Science,
University of Baghdad, Baghdad, Iraq;
3Department of Clinical Laboratory Sciences, College of Pharmacy,
Al-Nahrain University, Baghdad, Iraq;
4Department of Chemistry and Biochemistry, College of Medicine,
Al-Nahrain University, Baghdad, Iraq
*e-mail: Nesreen.ahmed@nahrainuniv.edu.iq

Received: 13 January 2026; Revised: 05 March 2026;
Accepted: 29 May 2026; Available on-line: 18 June 2026

Background. Polycystic ovary syndrome (PCOS) is an endocrine-metabolic disease with reproductive dysfunction, intricate hormonal imbalance, elevated risk of cardiovascular disease and obesity in women of reproductive age. Apelin, an adipokine, and corin, a serine protease which activates natriuretic peptide as a cardiovascular regulator, could be involved in the connection between reproductive endocrine imbalance and cardiometabolic regulation in this condition. Objective. To determine apelin and corin levels in the blood of women with PCOS and to evaluate whether they can be useful biochemical predictors for characterizing the disease and stratifying risks. Methods. The case-control study was conducted on 60 women, comprising 30 patients with PCOS and 30 healthy age- and demographically-matched controls. The levels of serum apelin and corin were evaluated with ELISA, that of hormones, 25-hydroxyvitamin D and B12 were analyzed with the help of a Finecare analyser. Results. Much higher apelin and corin levels, increased luteinizing hormone (LH) level and LH/follicle-stimulating hormone ratio, and lower 25-hydroxyvitamin D level in the serum of PCOS patients compared to healthy group were detected. Conclusions. The analysis of ROC curves showed significantly positive relationship between hormonal disturbance and the levels of circulating apelin and corin, indicating their higher PCOS diagnostic accuracy compared to the traditional hormonal markers.

Keywords: , , , ,

References:

  1. Azziz R, Woods KS, Reyna R, Key TJ, Knochenhauer ES, Yildiz BO. The prevalence and features of the polycystic ovary syndrome in an unselected population. J Clin Endocrinol Metab. 2004;89(6):2745-2749. PubMed, CrossRef
  2. Taylor AE, McCourt B, Martin KA, Anderson EJ, Adams JM, Schoenfeld D, Hall JE. Determinants of abnormal gonadotropin secretion in clinically defined women with polycystic ovary syndrome. J Clin Endocrinol Metab. 1997;82(7):2248-2256. PubMed, CrossRef
  3. Slowey MJ. Polycystic ovary syndrome: new perspective on an old problem. South Med J. 2001;94(2):190-196. PubMed
  4. Wild RA. Obesity, lipids, cardiovascular risk, and androgen excess. Am J Med. 1995;98(1A):27S-32S. PubMed, CrossRef
  5. Tatemoto K, Hosoya M, Habata Y, Fujii R, Kakegawa T, Zou MX, Kawamata Y, Fukusumi S, Hinuma S, Kitada C, Kurokawa T, Onda H, Fujino M. Isolation and characterization of a novel endogenous peptide ligand for the human APJ receptor. Biochem Biophys Res Commun. 1998;251(2):471-476. PubMed, CrossRef
  6. Ladeiras-Lopes R, Ferreira-Martins J, Leite-Moreira AF. The apelinergic system: the role played in human physiology and pathology and potential therapeutic applications. Arq Bras Cardiol. 2008;90(5):343-349. PubMed, CrossRef
  7. Shimizu T, Kosaka N, Murayama C, Tetsuka M, Miyamoto A. Apelin and APJ receptor expression in granulosa and theca cells during different stages of follicular development in the bovine ovary: Involvement of apoptosis and hormonal regulation. Anim Reprod Sci. 2009;116(1-2):28-37. PubMed, CrossRef
  8. Schilffarth S, Antoni B, Schams D, Meyer HH, Berisha B. The expression of apelin and its receptor APJ during different physiological stages in the bovine ovary. Int J Biol Sci. 2009;5(4):344-350. PubMed, PubMedCentral, CrossRef
  9. Boucher J, Masri B, Daviaud D, Gesta S, Guigné C, Mazzucotelli A, Castan-Laurell I, Tack I, Knibiehler B, Carpéné C, Audigier Y, Saulnier-Blache JS, Valet P. Apelin, a newly identified adipokine up-regulated by insulin and obesity. Endocrinology. 2005;146(4):1764-1771. PubMed, CrossRef
  10. Heinonen MV, Purhonen AK, Miettinen P, Pääkkönen M, Pirinen E, Alhava E, Akerman K, Herzig KH. Apelin, orexin-A and leptin plasma levels in morbid obesity and effect of gastric banding. Regul Pept. 2005;130(1-2):7-13. PubMed, CrossRef
  11. Reaux-Le Goazigo A, Morinville A, Burlet A, Llorens-Cortes C, Beaudet A. Dehydration-induced cross-regulation of apelin and vasopressin immunoreactivity levels in magnocellular hypothalamic neurons. Endocrinology. 2004;145(9):4392-4400. PubMed, CrossRef
  12. Ishida J, Hashimoto T, Hashimoto Y, Nishiwaki S, Iguchi T, Harada S, Sugaya T, Matsuzaki H, Yamamoto R, Shiota N, Okunishi H, Kihara M, Umemura S, Sugiyama F, Yagami K, Kasuya Y, Mochizuki N, Fukamizu A. Regulatory roles for APJ, a seven-transmembrane receptor related to angiotensin-type 1 receptor in blood pressure in vivo. J Biol Chem. 2004;279(25):26274-26279. PubMed, CrossRef
  13. Yan W, Sheng N, Seto M, Morser J, Wu Q. Corin, a mosaic transmembrane serine protease encoded by a novel cDNA from human heart. J Biol Chem. 1999;274(21):14926-14935. PubMed, CrossRef
  14. Langenickel TH, Pagel I, Buttgereit J, Tenner K, Lindner M, Dietz R, Willenbrock R, Bader M. Rat corin gene: molecular cloning and reduced expression in experimental heart failure. Am J Physiol Heart Circ Physiol. 2004;287(4):H1516-H1521. PubMed, CrossRef
  15. Gladysheva IP, King SM, Houng AK. N-glycosylation modulates the cell-surface expression and catalytic activity of corin. Biochem Biophys Res Commun. 2008;373(1):130-135. PubMed, CrossRef
  16. 1Liao X, Wang W, Chen S, Wu Q. Role of glycosylation in corin zymogen activation. J Biol Chem. 2007;282(38):27728-27735. PubMed, CrossRef
  17. Zhou Y, Wu Q. Role of corin and atrial natriuretic peptide in preeclampsia. Placenta. 2013;34(2):89-94. PubMed, PubMedCentral, CrossRef
  18. Cui Y, Wang W, Dong N, Lou J, Srinivasan DK, Cheng W, Huang X, Liu M, Fang C, Peng J, Chen S, Wu S, Liu Z, Dong L, Zhou Y, Wu Q. Role of corin in trophoblast invasion and uterine spiral artery remodelling in pregnancy. Nature. 2012;484(7393):246-250. PubMed, PubMedCentral, CrossRef
  19. Check JH, Dietterich C, Lurie D, Nazari A. No evidence of increased uterine vascular impedance with patient ageing following IVF. Hum Reprod. 2000;15(8):1679-1684. PubMed, CrossRef
  20. Zhang Y, Chen ZJ, Zhao H. Polycystic ovary syndrome: A metabolic disorder with therapeutic opportunities. Cell Metab. 2025;37(10):1932-1949. PubMed, CrossRef
  21. Stener-Victorin E, Teede H, Norman RJ, Legro R, Goodarzi MO, Dokras A, Laven J, Hoeger K, Piltonen TT. Polycystic ovary syndrome. Nat Rev Dis Primers. 2024;10(1):27. PubMed, CrossRef
  22. Zhang S, Jiang N, Liu G, Zhang B, Xu H, Xu Y, Qin G, Wang Y, Zhang L, Yang B, Han L. New perspectives on polycystic ovary syndrome: hypothalamic-sympathetic-adipose tissue interaction. J Ovarian Res. 2025;18(1):145. PubMed, PubMedCentral, CrossRef
  23. Li H, Sun S, Guo W, Wang L, Zhang Z, Zhang Y, Zhang C, Liu M, Zhang S, Niu Y, Dong N, Wu Q. Positively charged cytoplasmic residues in corin prevent signal peptidase cleavage and endoplasmic reticulum retention. Commun Biol. 2025;8(1):89. PubMed, PubMedCentral, CrossRef
  24. Shokrollahi B, Zheng HY, Li LY, Tang LP, Ma XY, Lu XR, Duan AQ, Zhang Y, Tan XH, Huang CX, Xu YY, Shang JH. Apelin and Apelin Receptor in Follicular Granulosa Cells of Buffalo Ovaries: Expression and Regulation of Steroidogenesis. Front Endocrinol (Lausanne). 2022;13:844360. PubMed, PubMedCentral, CrossRef
  25. Mehri K, Hamidian G, Zavvari Oskuye Z, Nayebirad S, Farajdokht F. The role of apelinergic system in metabolism and reproductive system in normal and pathological conditions: an overview. Front Endocrinol (Lausanne). 2023;14:1193150. PubMed, PubMedCentral, CrossRef
  26. Abdulmuttaleb NA, Oliwi Nasir AA, Alkubaisy SA, Mohsein OA. Investigation of Genetic Variations in APLN and APLNR Genes and Their Potential Role in Cardiovascular Diseases. Rep Biochem Mol Biol. 2025;13(4):525-539. PubMed, PubMedCentral, CrossRef
  27. Gao Y, Xin C, Fan H, Sun X, Wang H. Circulating apelin and chemerin levels in patients with polycystic ovary syndrome: A meta-analysis. Front Endocrinol (Lausanne). 2023;13:1076951. PubMed, PubMedCentral, CrossRef
  28. Ruan X, Li M, Min M, Ju R, Wang H, Xu Z, Luo S, Mueck AO. Plasma visfatin and apelin levels in adolescents with polycystic ovary syndrome. Gynecol Endocrinol. 2023;39(1):2216807. PubMed, CrossRef
  29. Mlyczyńska E, Kieżun M, Kurowska P, Dawid M, Pich K, Respekta N, Daudon M, Rytelewska E, Dobrzyń K, Kamińska B, Kamiński T, Smolińska N, Dupont J, Rak A. New Aspects of Corpus Luteum Regulation in Physiological and Pathological Conditions: Involvement of Adipokines and Neuropeptides. Cells. 2022;11(6):957. PubMed, PubMedCentral, CrossRef
  30. Sakban GH, Muhammed TM, Al-Tameemi ZAH, Mohsein OA. Exploring biomarkers, adipokines, and cytokines in patients with colon cancer: a comparative study with healthy controls. Regul Mech Biosyst. 2025;16(3):e25150. CrossRef
  31. Li H, Zhang Y, Liu C, Zhang Y, Yang H, Fu S, Lv H. Association of Insulin-Like Growth Factor-1 With Polycystic Ovarian Syndrome: A Systematic Review and Meta-analysis. Endocr Pract. 2023;29(5):388-397. PubMed, CrossRef
  32. Chen C, Jiang X, Ding C, Sun X, Wan L, Wang C. Downregulated lncRNA HOTAIR ameliorates polycystic ovaries syndrome via IGF-1 mediated PI3K/Akt pathway. Gynecol Endocrinol. 2023;39(1):2227280. PubMed, CrossRef
  33. Ozen FZ, Kaya-Sezginer E, Kırlangıc OF, Taskomur AT, Aktan F, Kaplan G, Ozgurtas T. Vascular endothelial growth factor (VEGF)-C and its receptors, soluble VEGFR-2 and VEGFR-3, in polycystic ovary syndrome. Turk J Biochem. 2024;49(2):266-273. CrossRef
  34. Ahmed AW, Abdul-QaderKhuder H, Jasim SAH, Mohsein OA. Hormonal profiles and metabolic changes in women diagnosed with concomitant Hashimoto’s thyroiditis and polycystic ovary syndrome via sonography. Eur J Clin Exp Med. 2025;23(3):596-604. CrossRef
  35. Matta RA, Saedii AA. Cross-Talk between Apelin, Insulin Resistance, Thyroid Hormones, and Cardio-metabolic Risk Factors in Polycystic Ovary Syndrome. Egypt J Hosp Med. 2022;87(1):1635–1643. CrossRef
  36. Ajeed AM, Naif NH, Farag AH, Mohsein OA. Assessing the impact of sleeve gastrectomy on micronutrient levels and inflammatory markers – a case-control study. Eur J Clin Exp Med. 2025;23(2):369-377. CrossRef
  37. Chen P, Jia R, Liu Y, Cao M, Zhou L, Zhao Z. Progress of Adipokines in the Female Reproductive System: A Focus on Polycystic Ovary Syndrome. Front Endocrinol (Lausanne). 2022;13:881684. PubMed, PubMedCentral, CrossRef
  38. Abdullah NN, Alameri MA, Muhammed TM, Mohsein OA. Role of Chemerin and Omentin in Predicting Ovulatory Dysfunction in Obese Women With Polycystic Ovary Syndrome (PCOS). Indones J Med Lab Sci Technol. 2026;8(1):76-83. CrossRef
Creative CommonsThis work is licensed under a Creative Commons Attribution 4.0 International License.